Navigation Links
Physicians Reconsider Implications of Enhance Trial
Date:2/7/2008

First Impact Report Reveals Shift in Prescribing Patterns As More MDs

Question Clinical Outcomes of Cholesterol-Reducing Drug

NEW YORK, Feb. 7 /PRNewswire/ -- Despite the controversy surrounding the release of the preliminary ENHANCE trial results on January 14, 2008, physicians are less concerned now -- roughly three weeks later -- about the trial results than they were initially, according to a pivotal FirstImpact Report issued today by FirstWord Publishing, publishers of the FirstWord newsletter, the world's leading source of news for the pharmaceutical industry.

The report, FirstImpact: ENHANCE trial results -- physicians evolving reactions, is based on surveys with general practitioners and cardiologists. The ENHANCE clinical trial results showed that Vytorin, a combination of Zetia and Zocor, is no more effective than Zocor in reducing plaque formation in patients with a condition that affects only about 0.2 percent of the population overall.

In the 48 hours after Merck/Schering-Plough released the preliminary results of the ENHANCE clinical trial, 82 percent of surveyed physicians responded that the results would have an impact on their prescribing decisions. A follow-up survey conducted by FirstImpact Reports on January 31 showed that this impact had decreased to 60 percent. Nonetheless, the FirstImpact survey also found that a large group of physicians continued to have negative reactions to the ENHANCE trial.

"There has been considerable speculation about the potential shifts in prescriptions of Vytorin and Zetia as a result of the ENHANCE trial results. But ultimately, it is the attitudes and treatment intentions of practicing physicians that determine how significantly prescriptions for these products will continue to be affected by the fallout of the ENHANCE trial," said Dominique Balas, president of FirstImpact Reports. She continues, "Our research found that while physicians' prescribing intentions have st
'/>"/>

SOURCE FirstImpact Reports
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Mayo Clinic Physicians Report Findings from Research on Sleep Disorders
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
4. Physicians Will Benefit from Medical Software Advice Website
5. Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
6. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
7. Improved Cornea Surgery Technique Provides Enhanced Transplant Success
8. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
9. Data Demonstrate that Obagi Medical Products Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
10. ReachMD Broadcasts First-of-its-Kind Physician Peer-Peer Discussion on ENHANCE Trial
11. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Pa., Nov. 20 In respons...ons why currently available medications designed t..., ECRI Institute, an independent nonprofit organiz...inasteride for Prevention of Prostate Cancer for ... York Times article, " Drugs to Deter Some Cancer...
(Date:11/19/2009)... 19 Warner Chilcott plc (Nasdaq: ...ly announced secondary offering of 20,000,000 of i....25 per share. The selling shareholders include f...rchant Banking, J.P. Morgan Partners (advised by C...tain other institutional investors and members of ...
(Date:11/19/2009)... Nov. 19 /PRNewswire-Asia/ -- ScinoPharm, a leadin...ents (APIs), announced that its,Tainan facility ha...n from,SafeBridge(R) Consultants, Inc. The Certifi...iency in the safe handling of potent active,pharma...ic laboratories and,production areas used for the ...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Some chest pain patients wait longer than 10 minutes to see ER physician 61033 1Some chest pain patients wait longer than 10 minutes to see ER physician 61033 2Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 6115 1Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 6115 2Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website 61031 1Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website 61031 2
...eting Also Showed No,Significant Impact on Weight ...ay 21, 2007 /PRNewswire-FirstCall/ --,Findings fro...,effect of desvenlafaxine succinate on anxious sym... with major depressive disorder,(MDD) -- as well a...ect of desvenlafaxine succinate on weight change i...
...of ten patients taking,once-daily Lialda remained ...D.C., May 22, 2007 /PRNewswire-FirstCall/ -- A,lon... study (303),presented at the British Society of G... in March 2007 showed Shire plc,s,Lialda(mesalamin...ts. Today, secondary endpoints of study 303 were p...
Other Medicine Technology:Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 2Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 4Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 5Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8
(Date:11/21/2009)...ntal Group merges their practice with that of E. S... (PRWEB) November 21, 2009 -- The Ne...vid Gibson, Dr. Dean Cloutier, Dr. John Plachtyna ...wing practice with that of esteemed colleague Dr. ... wanted to retire from dentistry in order to conce...
(Date:11/20/2009)...wswire-USNewswire/ -- The American Academy of Act... reform legislation released this week to contain ...ividual coverage mandate. The actuaries said that ... adverse selection stemming from more restrictive ..., "The individual mandate language should be stre...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Rates of infection by the... October, but the pandemic flu virus continues to ..., including the elderly, according to a new report... the world,s leading provider of diagnostic testin...cent Quest Diagnostics Health Trends(TM) Report "T...
(Date:11/20/2009)...0 Samuel Gladding is no...it means to be "happy" during the holidays. As a l... family counseling and chair of the Department of ...s research shows that it is the pressure to be hap... during the holidays. ,, That,s why he,s challe...
(Date:11/20/2009)...dehyde used for embalming in the funeral industry ...om myeloid leukemia, according to a new study publ...tional Cancer Institute . , Previous studies hav...malignancies and brain cancer in anatomists, patho... may have worked with formaldehyde. , For this...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2
... organised a public gathering here under the banne...abling of the reservation bill in the monsoon sess...protest was part of a nationwide programme, Youth ... the Supreme Court gives its verdict on the reserv...
...er surgery may experience nausea or vomiting, and ...e majority of patients won’t benefit from these dr... The review authors examined 737 studies invo...not been sufficiently studied. Not all surgi...
...niversity Medical Center have uncovered a protein ...re pain. They hope to manufacture drugs that are c...ng off. // Most prior attempts at alleviatin...vity of these neurons with drugs, though, because ...
...tioners have used the technique of 'distraction' w...any medical procedures. The technique of dis...ation in field of clinical practice, // is a proce...hesis that there is an important psychological ele...
...ded by the Economic and Social Research Council, r...technique in the UK, which is proving very success...cohol abuse. //The researchers have experimentally... habits thereby and drinking less. Researche...
...ed by transplanting human embryonic stem cell with...vine researchers.// UCI neurobiologist Hans K...ch Center found that rats with either mild or seve... result of the treatment itself. Furthermore, th...
Other Medicine News:Health News:Drugs for Postoperative Nausea May Not Help Most Patients 2Health News:Drugs for Postoperative Nausea May Not Help Most Patients 3Health News:It may be possible to switch off acute pain 2Health News:New Studies Show The Efficacies Of Virtual Realities Vis-à-vis Pai 2Health News:New Technique Developed To Help Fight The Problem Of Alcohol Abuse 2Health News:Treatment of Spinal Cord Injury with Embryonic Stem Cells 2
CROSSER™ 14 Coronary CTO Recanilazation System
...a 5X is a whole blood hematology control manufactu...20, and the Coulter AcT5diff instruments. The comp... differential, positioning the populations within ...The product offers 105-day closed-vial stability a...
...l-Chex is a spinal and body fluid control with dis...n the same manner as a patient sample, the white b...ntrol is assayed for manual cell counting, the fiv...he two-part polymorphonuclear and mononuclear diff...
Antelys Peek Lumbar Technologies
Medicine Products: